Sittner & Nelson’s Exact Sciences EXAS Stock Holding History

Sittner & Nelson’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-75	Closed	-$5.11K	–	493
2024 Q3	$5.11K	Hold	75	–	–	﹤0.01%	374
2024 Q2	$3.17K	Hold	75	–	–	﹤0.01%	410
2024 Q1	$5.18K	Hold	75	–	–	﹤0.01%	389
2023 Q4	$5.55K	Sell	75 -150	-67%	-$9.83K	﹤0.01%	383
2023 Q3	$15.3K	Hold	225	–	–	0.01%	298
2023 Q2	$21.1K	Hold	225	–	–	0.01%	274
2023 Q1	$15.3K	Hold	225	–	–	0.01%	327
2022 Q4	$11.1K	Hold	225	–	–	0.01%	331
2022 Q3	$7K	Sell	225 -75	-25%	-$3.09K	﹤0.01%	358
2022 Q2	$12K	Buy	300 +75	+33%	+$4.01K	0.01%	344
2022 Q1	$16K	Hold	225	–	–	0.01%	293
2021 Q4	$18K	Hold	225	–	–	0.01%	278
2021 Q3	$21K	Hold	225	–	–	0.01%	257
2021 Q2	$28K	Buy	225 +200	+800%	+$23.9K	0.02%	219
2021 Q1	$3K	Buy	+25	New	+$3.42K	﹤0.01%	354

Other funds holding EXAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sittner & Nelson's EXAS Position: Q4 2024 in Review

Sittner & Nelson sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 75 shares — an estimated $5.11K sold.

Sittner & Nelson first reported a position in EXAS in Q1 2021 and held it in 15 quarters. The position peaked at $28K in Q2 2021. 592 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

Sittner & Nelson reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
Sittner & Nelson sold 75 Exact Sciences shares in Q4 2024, an estimated $5.11K.
Sittner & Nelson first reported a position in Exact Sciences in Q1 2021 and held it in 15 quarters.
Sittner & Nelson's Exact Sciences position peaked at $28K in Q2 2021.
592 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Sittner & Nelson's 13F filing for Q4 2024, filed 11 Feb 2025.